Alvotech
Latest news
Investors
22 September 2022
Alvotech and STADA Increase Access to Adalimumab for Patients in Switzerland with the Launch of Hukyndra®
Investors
05 September 2022
Alvotech Reports Update on Initial AVT02 Biologics License Application
Investors
31 August 2022